Is Transfusion in Coronary Artery Surgery a Predictor or a Cause of Reduced Long-Term Survival?

Alexander Manché, Liberato Camilleri

Abstract


Background: Transfusion is common after coronary bypass surgery. Transfused patients present with higher operative risk and increased hazard ratio for curtailed long-term survival. There is debate as to whether transfusion itself may further exacerbate late mortality. Methods: Long-term survival was studied in 2550 survivors following coronary revascularization in this retrospective, observational study. Kaplan-Meier survival curves were constructed to compare all transfused and non-transfused patients, as well as survival in propensity-matched transfused and non-transfused patients. Results: Operative mortality was 1.05% (original cohort 2577). Maximum follow-up was 23 years (mean 11.8, median 12.4 years). 34.7% of patients received a transfusion (mean 2 units pack red blood cells). Baseline risk characteristics (age, female gender, small body habitus, risk stratification scoring, diabetes, hypertension and reduced stroke volume) operative parameters (urgency and no internal thoracic graft) as well as post-operative parameters (intensive care, hospital stay and ventilation time) and complications (haemorrhage, intra-aortic balloon, ventricular arrhythmias, prolonged inotropic support, atrial fibrillation, dialysis, doubling of creatinine and resternotomy) were higher in the transfused patients. The long-term survival of these patients was significantly reduced when compared with that of non-transfused patients (log rank test p<0.001). When analyzed as a sole risk factor, transfusion was associated with reduced long-term survival (log rank test p<0.001) but when analyzed collectively with other risk factors, transfusion failed to demonstrate a causative effect (p=0.953). When propensity matched groups were compared (612 transfused versus 1222 non-transfused patients) long-term survival was similar (log rank test p=0.554). Conclusions: Transfusion was required in higher risk patients undergoing coronary revascularization. Long-term survival was curtailed in this group but this was due to preoperative risk and not directly to transfusion. Transfusion was a predictor but not a cause of reduced long-term survival.

Keywords


blood transfusion; coronary artery bypass surgery; long-term survival

Full Text:

655-Manché

References


Geissler RG, Rotering H, Buddendick H, et al.: Utilization of blood components in cardiac surgery: a single-centre retrospective analysis with regard to diagnosis-related procedures. Transfus Med Hemother. 2015; 42(2): 75-82. Doi: 10.1159/000377691

Schwann TA, Habib JR, Khalifeh JM, et al.: Effects of blood transfusion on cause-specific late mortality after coronary artery bypass grafting – less is more. Ann Thorac Surg. 2016; 102(2): 465-473. Doi: 10.1016/j.athoracsur.2016.05.023

Bobich MP, Koch CG, Johnston DR, et al.: Trends in blood utilization in United States cardiac surgical patients. Transfusion. 2015; 55(4): 805-814. Doi: 10.1111/trf.12903

Ad N, Massimiano PS, Burton NA, et al.: Effect of patient age on blood product transfusion after cardiac surgery. J Thorac Cardiovasc Surg. 2015; 150(1): 209-214. Doi: 10.1016/j.jtcvs.2015.03.022

Acharya D, Gulack BC, Loyaga-Rendon RY, et al.: Clinical characteristics and outcomes of patients with myocardial infarction and cardiogenic shock undergoing coronary artery bypass surgery: data from the Society of Thoracic Surgeons National database. Ann Thorac Surg. 2016; 101(2): 558-566. Doi: 10.1016/j.athoracsur.2015.10.051

Koch CG: Tolerating anemia: taking aim at the right target before pulling the transfusion trigger. Transfusion. 2014; 54(10): 2595-2597. Doi: 10.1111/trf.12832

Paone G, Likosky DS, Brewer R, et al.: Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality. Ann Thorac Surg. 2014; 97(1): 87-93. Doi: 10.1016/j.athoracsur.2013.07.020

Kulier A, Levin J, Moser R, et al.: Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation. 2007; 116(5):471-479. Doi: 10.1161/CIRCULATIONAHA.106.653501

Corwin HL, Parsonnet KC, Gettinger A: RBC transfusion in the ICU. Is there a reason? Chest. 1995; 108(3): 767-771. Doi: 10.1378/chest.108.3.767

Lako A, Bilali S, Memishaj S, et al.: The impact of blood use on patients undergoing coronary artery bypass surgery: a prospective study. G Chir. 2014 35(1-2): 20-26. PMCID; PMC4321579

Patel NN, Avlonitis VS, Jones HE, et al.: Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis. Lancet Haematol. 2015; 2(12): e543-553. Doi: 10.1016/S2352-3026(15)00198-2

Paone G, Herbert MA, Theurer PF, et al.: Red blood cells and mortality after coronary artery bypass graft surgery: an analysis of 672 operative deaths. Ann thorac Surg. 2015; 99(5): 1583-1589. Doi: 10.1016/ j.athoracsur.2014.12.064

Jakobsen CJ, Ryhammer PK, Tang M, et al.: Transfusion of blood curing cardiac surgery is associated with higher long-term mortality in low-risk patients. Eur J Cardiothorac Surg. 2012; 42: 114-120. Doi: 10.1093/ejcts/ezr242

Dejam A, Malley BE, Feng M, et al.: The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients. Crit Care. 2014; 18(4): 487. Doi: 10.1186/s13054-014-0487-z

Shander A, Goodnough LT: Can blood transfusion be not only ineffective, but also injurious? Ann Thorac Surg. 2014; 97(1): 11-14. Doi: 10.1016/ j.athoracsur.2013.08.007

Engoren M, Arslanian-Engoren C: Long-term survival in the Intensive care unit after erythrocyte blood transfusion. Am J Crit Care. 2009; 18(2): 124-131. Doi: 10.4047/ajcc2009193

Vamvakas EC, Carven JH: RBC transfusion and postoperative length of stay in the hospital or the intensive care unit among patients undergoing coronary artery bypass graft surgery: the effects of confounding factors. Transfusion. 2000; 40(38): 832-830. Doi: 10.1046/j.1537-2995.2000.40070832.x

Kuduvali M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, et al.: Effect of peri-operative red cell transfusion on 30-day and 1-year mortaltity following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2005;27: 592-598. Doi: 10.1016/j.ejcts.2005.01.030

Kinnunen EM, Zanobini M, Onorati F, Brascia D, Mariscalco G, Franzese I, et al.: The impact of minor blood transfusion on the outcome after coronary artery bypass grafting. J Critical Care. 2017;40: 207-212. Doi: 10.1016/jjcrc.2017.04.025

Kuduvalli M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, et al.: Effect of peri-operative red blood cell transfusion on 30-day mortality and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2005;27: 592-598. Doi: 10.1016/j.ejcts.2005.01.030

Hardy JF, Martineau R, Courturier A, Belisle S, Cartier R, Carrier M. Influence of haemoglobin concentration after extra-corporeal circulation on mortality and morbidity in patients undergoing cardiac surgery. Br J Anaesth. 1998; 81(Suppl 1): 38-45. PMID: 10318987

Zallen G, Moore EE, Ciesla DJ, Brown M, Biffl WL, Silliman CC. Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. Shock. 2000; 13: 29-33. Doi: 19.1097/00024382-200013010-00006

Fransen E, Maessen J, Dentener M, Senden N, Buurman W. Impact of blood transfusion on inflammatory release in patients undergoing cardiac surgery. Chest. 1999; 116: 1233-1239. Doi: 10.1378/chest.116.5.1233

Surgenor SD, Kramer RS, Olmstead EM, Ross CS, Sellke FW, Likosky DS, et al.: The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg. 2009; 108:1741-1746. Doi: 10.1213/ane.0b013e3181a2a696

Weightman WM, Gibbs NM, Sheminant MR, Newman MAJ, Grey DE. Moderate exposure to allogeneic blood products is not associated with reduced long-term survival after surgery for coronary artery disease. Anesthesiology. 2009; 111:327-333. Doi: 10.1097/ALN.0b013e3181ab6743

Jakobsen C-J, Ryhammer PK, Tang M, Andreasen JJ, Mortensen PE. Transfusion of blood during cardiac surgery is associated with higher long-term mortality in low-risk patients. Eur J Cardiothorac Surg. 2012; 42:114-120. Doi: 10.1093/ejcts/ezr242

Blumberg N. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion. 2005; 45(Suppl 2): 33S-39S. Doi: 10.1111/j.1537-2995.2005.00529.x

Bennett-Guerrero E, Zhao Y, O’Brien SM, Ferguson TB, Peterson ED, Gammie JS, et al.: Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA. 2010; 304: 1568-1575. Doi: 10.1001/jama.2010.1406

Bidstrup BP. Blood transfusion: the epidemic continues. Eur J Cardiothorac Surg. 2012; 42: 120-121. Doi: 10.1093/ejcts/ezs007

Hajjar LA, Vincent JL, Galas FRBG, Nakamura RE, Silva CMP, Santos MH, et al.: Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010; 304: 1559-1567. Doi: 10.1001/jama.2010.1446

Shewan LG, Coats AJS, Henein MY. Authors’ Responsibilities and Ethical Publishing, International Cardiovasculat Forum Journal 2018;13:3-4. Doi: 10.17987/icfj.v13i0.525




DOI: https://doi.org/10.17987/icfj.v19i0.655

Copyright (c) 2020 The Authors

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.